{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:41:53Z","timestamp":1767840113823,"version":"3.49.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,7]]},"abstract":"<jats:p>Recent studies have reported that the lower airway microbiome may play an essential role in the development and progression of interstitial lung disease (ILD). The aim of the current study was to evaluate the characteristics of the respiratory microbiome and intrasubject variation in patients with ILD. Patients with ILD were recruited prospectively for 12 months. The sample size was small (n\u2005=\u200511) owing to delayed recruitment during the COVID-19 pandemic. All subjects were hospitalized and were evaluated by a questionnaire survey, blood sampling, pulmonary function test, and bronchoscopy. Bronchoalveolar lavage fluid (BALF) was obtained at 2 sites, the most and least disease-affected lesions. Sputum collection was also performed. Furthermore, 16S ribosomal RNA gene sequencing was performed using the Illumina platform and indexes of \u03b1- and \u03b2-diversity were evaluated. Species diversity and richness tended to be lower in the most-affected lesion than in the least-affected lesion. However, taxonomic abundance patterns were similar in these 2 groups. The phylum Fusobacteria was more prevalent in fibrotic ILD than in nonfibrotic ILD. Inter-sample differences in relative abundances were more prominent in BALF versus sputum specimens. <jats:italic toggle=\"yes\">Rothia<\/jats:italic> and <jats:italic toggle=\"yes\">Veillonella<\/jats:italic> were more prevalent in the sputum than in BALF. We did not detect site-specific dysbiosis in the ILD lung. BALF was an effective respiratory specimen type for evaluating the lung microbiome in patients with ILD. Further studies are needed to evaluate the causal links between the lung microbiome and the pathogenesis of ILD.<\/jats:p>","DOI":"10.1097\/md.0000000000033402","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T13:17:53Z","timestamp":1680873473000},"page":"e33402","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Characteristics and intrasubject variation in the respiratory microbiome in interstitial lung disease"],"prefix":"10.1097","volume":"102","author":[{"given":"Jun Yeun","family":"Cho","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Yeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Academic Cooperation Foundation, Chungbuk National University Industry, Cheongju, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hyoun","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eung-Gook","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biochemical and Medical Research Center, Chungbuk National University College of Medicine, Cheongju, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Hyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bumhee","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeran","family":"Kang","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Man","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang Hyeon","family":"Choe","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Mi","family":"Shin","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1164\/rccm.200503-483OE","article-title":"Clinical advances in the diagnosis and therapy of the interstitial lung diseases.","volume":"172","author":"King","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.amjms.2019.02.013","article-title":"Idiopathic pulmonary fibrosis: epidemiology, diagnosis and outcomes.","volume":"357","author":"Wakwaya","year":"2019","journal-title":"Am J Med Sci"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMra2116777","article-title":"Cryptogenic organizing pneumonia.","volume":"386","author":"King","year":"2022","journal-title":"New Engl J Med"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"210011","DOI":"10.1183\/16000617.0011-2021","article-title":"Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management.","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur Respir Rev"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-018-0730-2","article-title":"Idiopathic pulmonary fibrosis: pathogenesis and management.","volume":"19","author":"Sgalla","year":"2018","journal-title":"Respir Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.","volume":"366","author":"Raghu","year":"2012","journal-title":"New Engl J Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e27800","DOI":"10.1371\/journal.pone.0027800","article-title":"Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases.","volume":"6","author":"Lasithiotaki","year":"2011","journal-title":"PLoS One"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1164\/rccm.201010-1752OC","article-title":"Viral infection in acute exacerbation of idiopathic pulmonary fibrosis.","volume":"183","author":"Wootton","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.3748\/wjg.14.5880","article-title":"Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis.","volume":"14","author":"Arase","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R10-20250504","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/240805","article-title":"Ganciclovir antiviral therapy in advanced idiopathic pulmonary fibrosis: an open pilot study.","volume":"2011","author":"Egan","year":"2011","journal-title":"Pulm Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/thx.2008.110445","article-title":"Pulmonary infection in Wegener granulomatosis and idiopathic pulmonary fibrosis.","volume":"64","author":"Richter","year":"2009","journal-title":"Thorax"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/thoraxjnl-2012-202403","article-title":"Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial.","volume":"68","author":"Shulgina","year":"2013","journal-title":"Thorax"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"e8578","DOI":"10.1371\/journal.pone.0008578","article-title":"Disordered microbial communities in asthmatic airways.","volume":"5","author":"Hilty","year":"2010","journal-title":"PLoS One"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"e0176555","DOI":"10.1371\/journal.pone.0176555","article-title":"16S rRNA gene sequencing and healthy reference ranges for 28 clinically relevant microbial taxa from the human gut microbiome.","volume":"12","author":"Almonacid","year":"2017","journal-title":"PLoS One"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature06244","article-title":"The human microbiome project.","volume":"449","author":"Turnbaugh","year":"2007","journal-title":"Nature"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"190048","DOI":"10.1183\/16000617.0048-2019","article-title":"The microbiome in bronchiectasis.","volume":"28","author":"Richardson","year":"2019","journal-title":"Eur Respir Rev"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2017.11.036","article-title":"Interplay between the lung microbiome and lung cancer.","volume":"415","author":"Mao","year":"2018","journal-title":"Cancer Lett"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e16384","DOI":"10.1371\/journal.pone.0016384","article-title":"Analysis of the lung microbiome in the \u201chealthy\u201d smoker and in COPD.","volume":"6","author":"Erb-Downward","year":"2011","journal-title":"PLoS One"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-017-0511-3","article-title":"Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.","volume":"18","author":"Molyneaux","year":"2017","journal-title":"Respir Res"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S2213-2600(14)70069-4","article-title":"Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.","volume":"2","author":"Han","year":"2014","journal-title":"Lancet Respir Med"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: high-resolution sample inference from Illumina amplicon data.","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data.","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat Methods"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/01621459.1972.10481279","article-title":"Constructing confidence sets using rank statistics.","volume":"67","author":"Bauer","year":"1972","journal-title":"J Am Stat Assoc"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. an official ATS\/ERS\/JRS\/ALAT clinical practice guideline.","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1513\/AnnalsATS.201501-029OC","article-title":"Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography.","volume":"12","author":"Dickson","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/cmi.12308","article-title":"Defining dysbiosis and its influence on host immunity and disease.","volume":"16","author":"Petersen","year":"2014","journal-title":"Cell Microbiol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"280","DOI":"10.21037\/jtd.2018.12.88","article-title":"The microbiome and lung cancer.","volume":"11","author":"Maddi","year":"2019","journal-title":"J Thorac Dis"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41579-021-00559-y","article-title":"Prevotella diversity, niches and interactions with the human host.","volume":"19","author":"Tett","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"103851","DOI":"10.1016\/j.micpath.2019.103851","article-title":"Alveolar microbiota profile in patients with human pulmonary tuberculosis and interstitial pneumonia.","volume":"139","author":"V\u00e1zquez-P\u00e9rez","year":"2020","journal-title":"Microb Pathog"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1600746","DOI":"10.1183\/13993003.00746-2016","article-title":"Atopobium and Fusobacterium as novel candidates for sarcoidosis-associated microbiota.","volume":"50","author":"Zimmermann","year":"2017","journal-title":"Eur Respir J"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"2101293","DOI":"10.1183\/13993003.01293-2021","article-title":"Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease.","volume":"59","author":"Rigauts","year":"2022","journal-title":"Eur Respir J"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/thoraxjnl-2012-202917","article-title":"Microbial communities in the respiratory tract of patients with interstitial lung disease.","volume":"68","author":"Garzoni","year":"2013","journal-title":"Thorax"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/jnci\/djac149","article-title":"The oral microbiome and lung cancer risk: an analysis of 3 prospective cohort studies.","volume":"114","author":"Vogtmann","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"e02287","DOI":"10.1128\/mBio.02287-16","article-title":"Bacterial topography of the healthy human lower respiratory tract.","volume":"8","author":"Dickson","year":"2017","journal-title":"MBio"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.resinv.2019.09.004","article-title":"New procedure of bronchoalveolar lavage using a balloon catheter in diffuse lung diseases.","volume":"58","author":"Hotta","year":"2020","journal-title":"Respir Invest"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:23:52Z","timestamp":1746325432000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":35,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033402","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,7]]}}}